STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 4] Medpace Holdings, Inc. Insider Trading Activity

Medpace (MEDP) director converts 36 RSUs into common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medpace Holdings director Brian T. Carley exercised 36 restricted stock units into common stock on June 30, 2026. Following the transaction, he holds 32,825 shares of common stock and 71 remaining restricted stock units. The RSUs come from a 143-unit grant made on November 28, 2025.

Positive

  • None.

Negative

  • None.
Insider Carley Brian T
Role null
Type Security Shares Price Value
Exercise Restricted Stock Unit 36 $0.00 --
Exercise Common Stock 36 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 71 shares (Direct, null); Common Stock — 32,825 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
RSUs exercised 36 units Restricted stock units converted to common stock on June 30, 2026
Common shares after transaction 32,825 shares Direct Medpace common stock holdings following June 30, 2026 exercise
Remaining RSUs balance 71 units Restricted stock units held after June 30, 2026 transaction
Original RSU grant size 143 units Grant made on November 28, 2025 vesting in four installments
Restricted Stock Unit financial
"The filing lists a transaction involving "Restricted Stock Unit" as a derivative security."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share of MEDP common stock."
vests in four approximately equal installments financial
"143 restricted stock units vesting in four approximately equal installments on specific 2026 dates."
Exercise or conversion of derivative security financial
"The transaction code description states: Exercise or conversion of derivative security."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carley Brian T
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M36A(1)32,825D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/30/2026M36 (2) (2)Common Stock36$071D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
2. On November 28, 2025, the Reporting Person was granted 143 restricted stock units vesting in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.
Remarks:
/s/ Stephen P. Ewald, Attorney-in-Fact for Brian T. Carley07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Medpace (MEDP) director Brian T. Carley report?

Brian T. Carley reported exercising 36 restricted stock units into Medpace common stock. The transaction occurred on June 30, 2026 and is coded as an option or derivative security exercise rather than an open-market share purchase or sale.

How many Medpace (MEDP) shares does Brian T. Carley hold after this Form 4?

After the reported transaction, Brian T. Carley directly holds 32,825 shares of Medpace common stock. He also retains 71 restricted stock units, which represent additional contingent rights to receive Medpace shares in the future, subject to vesting conditions.

What type of securities were involved in Brian T. Carley’s Medpace (MEDP) filing?

The filing shows common stock and restricted stock units. Carley exercised 36 restricted stock units, each representing a contingent right to receive one share of Medpace common stock, converting them into 36 additional common shares held directly.

When were the restricted stock units in this Medpace (MEDP) Form 4 originally granted?

The restricted stock units were granted on November 28, 2025. The grant covered 143 units that vest in four approximately equal installments on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026, according to the filing footnotes.

How many restricted stock units remain after Brian T. Carley’s June 30, 2026 Medpace (MEDP) transaction?

Following the June 30, 2026 exercise of 36 restricted stock units, Brian T. Carley’s remaining restricted stock unit balance is 71. These RSUs continue to represent contingent rights to receive Medpace common stock as they vest under the original grant terms.

Is Brian T. Carley’s Medpace (MEDP) transaction an open-market buy or sell?

No, the transaction is classified as an exercise or conversion of a derivative security. The Form 4 uses transaction code M, showing a derivative exercise of restricted stock units rather than an open-market purchase or sale of Medpace shares.